Sculptor Capital’s Envoy Medical Warrant COCHW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$12.6K Buy
182,142
+5
+0% ﹤0.01% 345
2025
Q4
$7.89K Sell
182,137
-5
-0% ﹤0.01% 378
2025
Q3
$6.86K Hold
182,142
﹤0.01% 357
2025
Q2
$7.83K Hold
182,142
﹤0.01% 360
2025
Q1
$5.62K Hold
182,142
﹤0.01% 313
2024
Q4
$6.97K Hold
182,142
﹤0.01% 313
2024
Q3
$14.5K Hold
182,142
﹤0.01% 299
2024
Q2
$10.7K Hold
182,142
﹤0.01% 284
2024
Q1
$19.4K Hold
182,142
﹤0.01% 274
2023
Q4
$4.28K Hold
182,142
﹤0.01% 344
2023
Q3
$15K Hold
182,142
﹤0.01% 335
2023
Q2
$8.51K Hold
182,142
﹤0.01% 384
2023
Q1
$6.41K Sell
182,142
-2,500
-1% -$141 ﹤0.01% 499
2022
Q4
$7.26K Hold
184,642
﹤0.01% 703
2022
Q3
$11K Hold
184,642
﹤0.01% 952
2022
Q2
$20K Hold
184,642
﹤0.01% 1022
2022
Q1
$44K Hold
184,642
﹤0.01% 1091
2021
Q4
$144K Hold
184,642
﹤0.01% 908
2021
Q3
$121K Hold
184,642
﹤0.01% 820
2021
Q2
$197K Buy
+184,642
New +$132K ﹤0.01% 756

Other funds holding COCHW

Sculptor Capital's COCHW Position: Q1 2026 in Review

Sculptor Capital increased its Envoy Medical Warrant (COCHW) stake by 0% in Q1 2026, adding 5 shares and bringing the position to 182,142 shares worth $12.6K. The position accounts for ﹤0.01% of the portfolio, ranked #345.

Sculptor Capital first reported a position in COCHW in Q2 2021 and has held it in 20 quarters since. The position peaked at $197K in Q2 2021. 34 funds tracked by Wall St. Rank hold COCHW as of Q1 2026.

  • Sculptor Capital held 182,142 shares of Envoy Medical Warrant worth $12.6K as of Q1 2026.
  • Sculptor Capital bought 5 Envoy Medical Warrant shares in Q1 2026.
  • Envoy Medical Warrant made up ﹤0.01% of Sculptor Capital's portfolio in Q1 2026, its #345 holding.
  • Sculptor Capital first reported a position in Envoy Medical Warrant in Q2 2021 and has held it in 20 quarters since.
  • Sculptor Capital's Envoy Medical Warrant position peaked at $197K in Q2 2021.
  • 34 funds tracked by Wall St. Rank held Envoy Medical Warrant as of Q1 2026.

Based on Sculptor Capital's 13F filing for Q1 2026, filed 15 May 2026.